Trade Summary

Yesterday, OYLER JOHN, serving as Chief Executive Officer at BeOne Medicines Ltd. (ONC), sold 145,861 shares at $305.95 per share, for a total transaction value of $44,626,424.10.

This sale represents a 100.00% decrease in OYLER JOHN's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 14, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 15, 2026 (accepted Jul 14, 9:26 PM ET), 1 day after the trade was made.

BeOne Medicines Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.